GO:0055020 positive regulation of cardiac muscle fiber development: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055020 describes any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development.
• Cardiac muscle fiber development is a tightly regulated biological process essential for heart formation and function, and its dysregulation contributes to myocardial ischemia-reperfusion injury, cardiac hypertrophy, and heart failure [1,6].
• Key molecular regulators include S100a9, NAD+ metabolism, SENP1, HSP90ab1, circMIRIAF, miR-544, WDR12, histamine N-methyltransferase, and mitophagy-related proteins [1,2,4,5,6,8].
• Post-translational modifications such as lactylation and SUMOylation modulate cardiac muscle fiber development and stress responses [1,3,4].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of genes in positive regulation of cardiac muscle fiber development [1,4,5].
• Understanding GO:0055020 provides mechanistic insights into cardiac disease and identifies potential therapeutic targets for heart failure and ischemic injury [1,6].
Description
GO:0055020, positive regulation of cardiac muscle fiber development, is a Gene Ontology biological process term that encompasses any process which activates, maintains, or increases the frequency, rate, or extent of cardiac muscle fiber development. Cardiac muscle fibers are the contractile units of the heart, and their proper development is critical for normal cardiac function. Disruption of this process is associated with severe cardiac pathologies, including myocardial ischemia-reperfusion injury, cardiac hypertrophy, and heart failure [1,6]. Recent studies have identified diverse molecular players that positively regulate cardiac muscle fiber development, ranging from metabolic regulators such as NAD+ to post-translational modifiers like SENP1 and lactylation-driven signaling [1,3]. Understanding the mechanisms that govern this process is essential for developing therapeutic strategies to combat heart disease. This article synthesizes current knowledge on the positive regulation of cardiac muscle fiber development, highlighting key genes, regulatory pathways, disease associations, and cutting-edge research methodologies including CRISPR-based genome editing.
positive regulation of cardiac muscle fiber development At A Glance
| GO ID | GO:0055020 |
|---|---|
| GO term | positive regulation of cardiac muscle fiber development |
| Ontology | biological_process |
| Synonym | activation of cardiac muscle fiber development; positive regulation of cardiac muscle fibre development; positive regulation of heart muscle fiber development; stimulation of cardiac muscle fiber development; up regulation of cardiac muscle fiber development; up-regulation of cardiac muscle fiber development; upregulation of cardiac muscle fiber development |
| Major function | Promotes the frequency, rate, or extent of cardiac muscle fiber development, essential for heart formation and contractile function. |
| Related processes | Cardiac muscle tissue development, cardiac muscle cell differentiation, heart morphogenesis. |
| Disease relevance | Myocardial ischemia-reperfusion injury, cardiac hypertrophy, heart failure, diabetic cardiomyopathy. |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, animal models. |
What Is GO:0055020?
According to the Gene Ontology, GO:0055020 is defined as any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development. In other words, it includes all molecular events and signaling pathways that promote the formation, maturation, and functional integration of cardiac muscle fibers, which are the specialized contractile cells of the heart. This term is a child of positive regulation of cardiac muscle tissue development and is distinct from negative regulation or the basal developmental process itself.
Why Is positive regulation of cardiac muscle fiber development Important in Cell Biology?
Positive regulation of cardiac muscle fiber development is fundamental to heart health because it ensures the proper formation and maintenance of contractile units. Dysregulation of this process leads to impaired cardiac function and contributes to the pathogenesis of various cardiovascular diseases, including ischemic injury, hypertrophy, and heart failure [1,6]. Understanding the molecular mechanisms that positively regulate cardiac muscle fiber development can reveal therapeutic targets and biomarkers for diagnosing and treating heart disease.
• Essential for normal heart development and contractile function.
• Dysregulation contributes to myocardial ischemia-reperfusion injury.
• Linked to cardiac hypertrophy and heart failure.
• Involved in diabetic cardiomyopathy through mitophagy regulation.
• Modulated by NAD+ metabolism, affecting cardiac aging and disease.
• Regulated by post-translational modifications such as lactylation and SUMOylation [1,3,4].
• Provides targets for CRISPR-based therapeutic genome editing.
• Serves as a model for studying gene regulatory networks in cardiac biology.
• Impacts regenerative medicine approaches for heart repair.
• Critical for understanding sex-specific and age-related cardiac differences.
What Happens During positive regulation of cardiac muscle fiber development?
Initiation of cardiac muscle fiber development
In simple terms: The process starts when cardiac progenitor cells receive signals to become muscle fibers.
Positive regulation of cardiac muscle fiber development begins with the activation of transcription factors and signaling pathways that commit cardiac progenitor cells to the cardiomyocyte lineage. Key metabolic cues, such as NAD+ levels, influence this commitment by modulating redox state and energy production. Additionally, post-translational modifications like lactylation on histones can alter gene expression programs that drive cardiac muscle fiber development [1,3].
Elongation and maturation of cardiac muscle fibers
In simple terms: Newly formed muscle cells grow longer and assemble contractile proteins.
During elongation, cardiac muscle fibers undergo structural maturation, including sarcomere assembly and organization. Proteins such as HSP90ab1 are deSUMOylated by SENP1, which prevents myocardial fibrosis and supports proper fiber development through paracrine signaling. The circMIRIAF/miR-544/WDR12 axis has been implicated in aggravating ischemia-reperfusion injury, suggesting that fine-tuning of these molecules is critical for positive regulation.
Metabolic and redox regulation
In simple terms: The cell's energy status and chemical modifications control how fast fibers develop.
NAD+ metabolism plays a central role in cardiac health and disease, influencing mitochondrial function and stress responses that impact muscle fiber development. Lactate accumulation and histone lactylation in vascular smooth muscle cells can aggravate aortic aneurysm, indicating that metabolic remodeling affects cardiac muscle fiber regulation. Mitophagy is essential for maintaining cardiac function during high-fat diet-induced diabetic cardiomyopathy, highlighting the importance of organelle quality control in positive regulation.
Inflammatory and immune modulation
In simple terms: Inflammation can either help or harm muscle fiber development depending on context.
S100a9 lactylation triggers neutrophil trafficking and cardiac inflammation in myocardial ischemia-reperfusion injury, which can negatively impact cardiac muscle fiber development. Conversely, histamine N-methyltransferase upregulation is associated with cardiac hypertrophy and heart failure, suggesting that histamine metabolism may modulate positive regulation of cardiac muscle fiber development. Thus, inflammatory mediators must be tightly regulated to promote proper fiber development.
Key Genes Involved in GO:0055020 positive regulation of cardiac muscle fiber development
The following genes and proteins have been experimentally implicated in the positive regulation of cardiac muscle fiber development or related cardiac processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| S100a9 | Lactylation triggers neutrophil trafficking and cardiac inflammation | Implicated in myocardial ischemia-reperfusion injury |
| NAD+ | Cofactor in redox reactions and mitochondrial metabolism | Regulates cardiac health, aging, and disease |
| SENP1 | DeSUMOylates HSP90ab1 in cardiomyocytes | Prevents myocardial fibrosis via paracrine signaling |
| HSP90ab1 | Chaperone protein involved in protein folding | Target of SENP1-mediated deSUMOylation |
| circMIRIAF | Circular RNA that sponges miR-544 | Aggravates myocardial ischemia-reperfusion injury |
| miR-544 | MicroRNA targeting WDR12 | Involved in ischemia-reperfusion injury |
| WDR12 | WD repeat domain protein | Target of miR-544 in cardiac injury |
| HNMT | Histamine N-methyltransferase | Upregulation linked to cardiac hypertrophy and heart failure |
| Mitophagy proteins | Mediate autophagic removal of damaged mitochondria | Essential for cardiac function in diabetic cardiomyopathy |
| Histone lactylation | Epigenetic modification | Metabolic remodeling in vascular smooth muscle cells |
| Neutrophil trafficking factors | Immune cell recruitment | Cardiac inflammation in ischemia-reperfusion |
| Paracrine signaling molecules | Cell-cell communication | Prevent myocardial fibrosis |
| Mitochondrial quality control factors | Maintain mitochondrial integrity | Cardiac function during metabolic stress |
| Redox regulators | Balance oxidative stress | Cardiac aging and disease |
| SUMOylation machinery | Post-translational modification | Regulates cardiomyocyte proteins |
| Lactate transporters | Regulate lactate flux | Metabolic remodeling in cardiac tissue |
| Inflammatory cytokines | Modulate immune response | Cardiac injury and repair |
| Histamine receptors | G-protein coupled receptors | Cardiac hypertrophy signaling |
How Is positive regulation of cardiac muscle fiber development Regulated?
Positive regulation of cardiac muscle fiber development is controlled by a complex network of signaling pathways, including NAD+-dependent sirtuin activity, SUMOylation/deSUMOylation cycles, and lactylation-mediated epigenetic changes [1,3]. Mitophagy also plays a regulatory role by maintaining mitochondrial quality control. These pathways integrate metabolic, inflammatory, and stress signals to fine-tune cardiac muscle fiber development.
positive regulation of cardiac muscle fiber development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| S100a9 | Myocardial ischemia-reperfusion injury | Knockout mouse, overexpression in cardiomyocytes |
| SENP1 | Myocardial fibrosis | Cardiomyocyte-specific knockout, knock-in |
| circMIRIAF | Ischemia-reperfusion injury | Overexpression and knockdown in cardiac cells |
| HNMT | Cardiac hypertrophy and heart failure | Transgenic overexpression, knockout |
| Mitophagy genes | Diabetic cardiomyopathy | Conditional knockout, mitophagy reporters |
Myocardial ischemia-reperfusion injury
S100a9 lactylation triggers neutrophil trafficking and cardiac inflammation, exacerbating myocardial ischemia-reperfusion injury and impairing cardiac muscle fiber development. The circMIRIAF/miR-544/WDR12 axis also aggravates this injury, suggesting that positive regulation of cardiac muscle fiber development is disrupted in ischemic heart disease.
Cardiac hypertrophy and heart failure
Upregulation of histamine N-methyltransferase is associated with cardiac hypertrophy and heart failure, indicating that histamine metabolism may influence positive regulation of cardiac muscle fiber development. NAD+ metabolism also declines with age and heart failure, contributing to impaired cardiac function.
Diabetic cardiomyopathy
Mitophagy is essential for maintaining cardiac function during high-fat diet-induced diabetic cardiomyopathy, and its impairment leads to cardiac dysfunction. This suggests that positive regulation of cardiac muscle fiber development is compromised in diabetic hearts.
Myocardial fibrosis
SENP1-mediated deSUMOylation of HSP90ab1 in cardiomyocytes prevents myocardial fibrosis by paracrine signaling, highlighting a protective role in cardiac muscle fiber development. Dysregulation of this pathway may contribute to fibrotic heart disease.
From positive regulation of cardiac muscle fiber development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate cardiac muscle fiber development? | CRISPR knockout in cardiomyocytes or mouse models |
| What is the effect of a specific point mutation in gene Y? | CRISPR point mutation knock-in |
| How does tagging a protein affect its function? | CRISPR knock-in of epitope tag |
| Does overexpression of gene Z enhance fiber development? | CRISPR activation or cDNA overexpression |
| Which genes are essential for cardiac muscle fiber development? | Genome-wide CRISPR library screening |
| What are the downstream targets of a regulator? | RNA-seq and proteomics after CRISPR perturbation |
How to Study the positive regulation of cardiac muscle fiber development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Identify essential genes |
| CRISPR activation | Gain-of-function phenotype | Discover positive regulators |
| RNA-seq | Transcriptome changes | Gene expression profiling |
| Proteomics | Protein abundance and modifications | Identify post-translational changes |
| ChIP-seq | Histone modifications and TF binding | Epigenetic regulation |
| Imaging | Sarcomere structure and contractility | Functional assessment |
| Mitophagy assays | Autophagic flux | Mitochondrial quality control |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of cardiac muscle fiber development. These screens use pooled sgRNA libraries to perturb thousands of genes and select for phenotypes such as enhanced cardiomyocyte differentiation or contractility [1,4].
Transcriptomic and proteomic profiling
RNA-seq and mass spectrometry-based proteomics can reveal gene expression and protein abundance changes during cardiac muscle fiber development. For example, lactylation and SUMOylation targets can be mapped using specific enrichment strategies [1,3,4].
Imaging and functional assays
High-content imaging of sarcomere structure and contractility assays in cardiomyocytes derived from CRISPR-edited stem cells can directly assess the effects of genetic perturbations on cardiac muscle fiber development [5,8].
Animal models and lineage tracing
Conditional knockout and knock-in mouse models allow studying gene function in vivo. Lineage tracing can track the fate of cardiac progenitor cells and their contribution to muscle fiber development [2,6].
How CRISPR Can Be Used to Study GO:0055020 positive regulation of cardiac muscle fiber development
Knockout
CRISPR knockout of candidate genes in cardiomyocytes or animal models can determine whether they are required for positive regulation of cardiac muscle fiber development. For example, knocking out SENP1 or mitophagy-related genes can reveal their roles in cardiac function [4,8].
Point Mutation
Introducing specific point mutations using CRISPR base editing or homology-directed repair can model human variants and assess their impact on cardiac muscle fiber development. This is particularly useful for studying post-translational modification sites, such as lactylation or SUMOylation sites [1,4].
Knock-in
Knock-in of reporter genes or epitope tags allows visualization and biochemical analysis of proteins involved in cardiac muscle fiber development. For instance, tagging HSP90ab1 can help track its deSUMOylation by SENP1.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can upregulate genes to test whether they positively regulate cardiac muscle fiber development. Overexpressing NAD+ biosynthetic enzymes or S100a9 can mimic disease states [1,2].
How EDITGENE Supports positive regulation of cardiac muscle fiber development Research
Researchers studying positive regulation of cardiac muscle fiber development-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cardiac muscle fiber development research.
Frequently Asked Questions About positive regulation of cardiac muscle fiber development
What is GO:0055020?
GO:0055020 is the Gene Ontology term for positive regulation of cardiac muscle fiber development, defined as any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development.
What genes are involved in positive regulation of cardiac muscle fiber development?
Key genes include S100a9, SENP1, HSP90ab1, circMIRIAF, miR-544, WDR12, HNMT, and mitophagy-related genes [1,4,5,6,8].
How is cardiac muscle fiber development regulated?
It is regulated by metabolic cues like NAD+, post-translational modifications such as lactylation and SUMOylation [1,3,4], and inflammatory signals [1,6].
What diseases are associated with dysregulation of cardiac muscle fiber development?
Myocardial ischemia-reperfusion injury, cardiac hypertrophy, heart failure, diabetic cardiomyopathy, and myocardial fibrosis [1,4,5,6,8].
What research methods are used to study GO:0055020?
CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, and animal models [1,4,5,8].
How can CRISPR be used to study positive regulation of cardiac muscle fiber development?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to test gene function in cardiac cells [1,4,5].
What is the role of NAD+ in cardiac muscle fiber development?
NAD+ metabolism influences cardiac health, aging, and disease by regulating redox state and mitochondrial function.
What is the role of SENP1 in the heart?
SENP1 deSUMOylates HSP90ab1 in cardiomyocytes, preventing myocardial fibrosis and supporting cardiac muscle fiber development.
How does lactylation affect cardiac muscle fibers?
Lactylation of histones and proteins like S100a9 can trigger inflammation and metabolic remodeling, impacting cardiac muscle fiber development [1,3].
What is the significance of mitophagy in cardiac muscle fiber development?
Mitophagy maintains mitochondrial quality control and is essential for cardiac function during diabetic cardiomyopathy.
Conclusion
Positive regulation of cardiac muscle fiber development (GO:0055020) is a critical biological process that ensures proper heart formation and function. Dysregulation of this process contributes to major cardiovascular diseases, including ischemic injury, hypertrophy, and heart failure. Recent research has uncovered key molecular players such as S100a9, SENP1, and NAD+ metabolism, as well as the importance of post-translational modifications and mitophagy. CRISPR-based genome editing tools offer powerful approaches to dissect these mechanisms and identify therapeutic targets. EDITGENE provides comprehensive services to support researchers in this field, from knockout models to library screening and bioinformatics.
References
- 1. Wang X et al.. 2025. S100a9 lactylation triggers neutrophil trafficking and cardiac inflammation in myocardial ischemia/reperfusion injury.. J Clin Invest 135(24) PMID: 41066195
- 2. Abdellatif M et al.. 2021. NAD(+) Metabolism in Cardiac Health, Aging, and Disease.. Circulation 144(22):1795-1817 PMID: 34843394
- 3. Liu L et al.. 2026. Histone Lactylation-Mediated Metabolic Remodeling in Vascular Smooth Muscle Cells Aggravates Aortic Aneurysm and Dissection by Promoting Lactate Accumulation.. Circulation 153(3):189-209 PMID: 41487086
- 4. Liu Z et al.. 2024. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling.. Adv Sci (Weinh) 11(34):e2400741 PMID: 38992961
- 5. Yin L et al.. 2024. circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis.. Redox Biol 73:103175 PMID: 38795544
- 6. Zhang J et al.. 2026. Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure.. Eur Heart J 47(19):2345-2363 PMID: 41568626
- 8. Tong M et al.. 2019. Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy.. Circ Res 124(9):1360-1371 PMID: 30786833
